News & Perspective

May 04, 2018

May 04, 2018

ASP Scan (Weekly) for May 04, 2018

Antibiotic resistance in ICUs
Nurses' role in stewardship
Klebsiella pneumoniae in Germany
New antibiotic for UTIs
Hypervirulent, drug-resistant Klebsiella
Stewardship in primary care
Variant MCR-3 gene
Resistant H pylori in Africa

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Jul 11, 2017

Jul 11, 2017

News Scan for Jul 11, 2017

Cholera in Yemen and South Sudan
Saudi MERS case
Global flu update
Measles in Europe
Sanofi to acquire Protein Sciences
H5N8 in South Africa

Dec 20, 2013

Dec 20, 2013

Flu Scan for Dec 20, 2013

ECDC weighs H7N9 threat
Firm seeks peramivir approval

Apr 24, 2013

Apr 24, 2013

Taiwan reports first H7N9 case outside of China

(CIDRAP News) – Taiwan health officials today announced that a 53-year-old man who had recently traveled to China is hospitalized in critical condition with a novel H7N9 infection, the first such case to be detected outside of China.

Jun 03, 2011

Jun 03, 2011

Four US cases may be tied to European E coli outbreak

(CIDRAP News) – The case count in Europe's unprecedented Escherichia coli outbreak climbed steeply again today as the number of potentially related cases in the United States rose to four, while a scientific debate continued on whether the outbreak strain, E coli O104:H4, is new or unique.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Sort Results By:

 Sort Results By:

Narrow results by:

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»